FRANCE�MEIMENG�INTERNATIONAL�CO.,�LIMITED – Trademark Portfolio

Entity Type: 99

FRANCE�MEIMENG�INTERNATIONAL�CO.,�LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include LOTINLAB. The owner is based in HONG�KONG.

ROOM 1508,15TH FLOOR,OFFICE BUILDING II,GRAND PLAZA,625 NATHAN ROAD, KOWLOON,HONG KONG

HONG�KONG , HK

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

LOTINLAB
LOTINLAB
Registered 2021

Trademark Classifications

FRANCE�MEIMENG�INTERNATIONAL�CO.,�LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does FRANCE�MEIMENG�INTERNATIONAL�CO.,�LIMITED have?

FRANCE�MEIMENG�INTERNATIONAL�CO.,�LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does FRANCE�MEIMENG�INTERNATIONAL�CO.,�LIMITED file in?

FRANCE�MEIMENG�INTERNATIONAL�CO.,�LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are FRANCE�MEIMENG�INTERNATIONAL�CO.,�LIMITED's most well-known trademarks?

FRANCE�MEIMENG�INTERNATIONAL�CO.,�LIMITED's registered trademark portfolio includes well-known marks such as LOTINLAB. These are among 1 currently registered trademark in the portfolio.

What is FRANCE�MEIMENG�INTERNATIONAL�CO.,�LIMITED's trademark registration success rate?

FRANCE�MEIMENG�INTERNATIONAL�CO.,�LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.